SARMs

Ostarine

Also known as: MK-2866 · Enobosarm · GTx-024

The most studied SARM — muscle preservation and injury recovery.

Half-Life
~24 hours
Administration
Oral
Category
SARMs
Citations
1 studies

What is Ostarine?

Ostarine (MK-2866) is the most extensively researched selective androgen receptor modulator (SARM). It was developed by GTx Inc. for muscle wasting and osteoporosis. It has completed Phase II clinical trials and is the SARM with the most human safety data. It is widely used for muscle preservation during caloric deficits, injury recovery, and as a mild anabolic.

Mechanism of Action

Ostarine selectively binds to androgen receptors in muscle and bone tissue with high affinity, activating anabolic signaling (protein synthesis, nitrogen retention) without significant activation of androgen receptors in the prostate, skin, or liver. This tissue selectivity is what distinguishes SARMs from anabolic steroids.

Ostarine Dosing Protocol

10–25 mg/day oral. For muscle preservation/cutting: 10–15 mg/day. For lean bulking: 20–25 mg/day. Cycle: 8–12 weeks. PCT (post-cycle therapy) may be needed at higher doses — monitor testosterone levels.

Administration Routes
Oral
Half-Life
~24 hours

Want a personalized protocol? Tell PepBot your goals, health status, and experience level for a custom Ostarine protocol.

Ostarine Benefits

Muscle preservation during caloric deficit
Lean muscle gain
Improved bone density
Injury recovery (tendons, ligaments)
Minimal side effects vs anabolic steroids
Extensive human safety data (Phase II trials)

Side Effect Profile

Mild testosterone suppression at higher doses (20–25 mg/day), mild liver enzyme elevation (monitor), potential lipid changes. Significantly safer than anabolic steroids. PCT may be needed after longer/higher-dose cycles.

Ostarine Stacking Guide

Ostarine works synergistically with these compounds. Click any to learn more, or ask PepBot to build you a complete stack.

Research & Citations

Frequently Asked Questions about Ostarine

Does Ostarine require PCT?
At low doses (10–15 mg/day) for 8 weeks, most users experience minimal testosterone suppression and may not need PCT. At higher doses (20–25 mg/day) or longer cycles (12+ weeks), mild testosterone suppression occurs and a short PCT (Nolvadex 20 mg/day for 4 weeks) is recommended. Always get bloodwork before and after.

Still have questions about Ostarine?

PepBot has encyclopedic knowledge of Ostarine — dosing, stacking, interactions, latest research, and personalized protocols. Ask anything.